APOE and Alzheimer disease: Similar results have been seen in non-clinical, potentially at-risk individuals; those carrying the APOE4 genotype (associated with increased AD risk) displayed reduced practice effects on longitudinal cognitive measures compared to individuals without these alleles (Donix et al., 2012).